Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.67)
# 3,127
Out of 4,735 analysts
187
Total ratings
39.24%
Success rate
-5.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVRO Nevro | Downgrades: Underweight | $9 → $4 | $4.68 | -14.53% | 9 | Dec 2, 2024 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $604.12 | +7.59% | 13 | Dec 2, 2024 | |
| SGHT Sight Sciences | Maintains: Equal-Weight | $7 → $5 | $2.89 | +73.01% | 15 | Nov 11, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $18.63 | -35.59% | 12 | Jul 15, 2024 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $135 → $130 | $108.71 | +19.58% | 15 | Jul 15, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $130 → $120 | $110.52 | +8.58% | 11 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $56.73 | +67.46% | 12 | Feb 28, 2024 | |
| MDT Medtronic | Maintains: Overweight | $104 → $98 | $88.38 | +10.88% | 9 | Nov 22, 2023 | |
| NARI Inari Medical | Reiterates: Overweight | $83 | $79.50 | +4.40% | 10 | Aug 3, 2023 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $88.54 | -4.00% | 9 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $15 | $31.59 | -52.52% | 4 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $325 → $343 | $276.08 | +24.24% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $6.19 | +126.17% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $31.48 | +52.48% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $69.97 | +45.78% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $100.91 | -42.52% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $17.18 | +16.41% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $86.32 | +51.76% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $116.79 | +13.88% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $395.85 | -44.42% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $182.45 | +107.18% | 2 | Feb 25, 2022 |
Nevro
Dec 2, 2024
Downgrades: Underweight
Price Target: $9 → $4
Current: $4.68
Upside: -14.53%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $604.12
Upside: +7.59%
Sight Sciences
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.89
Upside: +73.01%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $18.63
Upside: -35.59%
iRhythm Technologies
Jul 15, 2024
Maintains: Overweight
Price Target: $135 → $130
Current: $108.71
Upside: +19.58%
Zimmer Biomet Holdings
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $130 → $120
Current: $110.52
Upside: +8.58%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $56.73
Upside: +67.46%
Medtronic
Nov 22, 2023
Maintains: Overweight
Price Target: $104 → $98
Current: $88.38
Upside: +10.88%
Inari Medical
Aug 3, 2023
Reiterates: Overweight
Price Target: $83
Current: $79.50
Upside: +4.40%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $88.54
Upside: -4.00%
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $31.59
Upside: -52.52%
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $276.08
Upside: +24.24%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $6.19
Upside: +126.17%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $31.48
Upside: +52.48%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $69.97
Upside: +45.78%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $100.91
Upside: -42.52%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $17.18
Upside: +16.41%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $86.32
Upside: +51.76%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $116.79
Upside: +13.88%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $395.85
Upside: -44.42%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $182.45
Upside: +107.18%